Objective: The US Food and Drug Administration (FDA) issued a warning stating that
patients older than 60 years are not recommended to receive doses of citalopram exceeding …

Objectives In 2011, the US Food and Drug Administration (FDA) issued a safety
announcement cautioning providers against prescribing citalopram above 40 mg per day …

Objective: A public safety communication issued by the Food and Drug Administration
declared that citalopram dosages exceeding 40 mg/day were no longer considered safe …

Objective In 2011–2012 the US Food and Drug Administration (FDA) issued safety
announcements cautioning providers against prescribing high doses of citalopram given …

Introduction: Recently, controversy has surrounded a 2011 Food and Drug Administration
warning against using citalopram at doses> 40 mg/day due to QTc prolonging effects …

Citalopram (Celexa, Forest Laboratories, New York, NY) is one of the most widely
prescribed selective serotonin reuptake inhibitors (SSRIs) in our practice. It has had good …

Background Citalopram is the most commonly prescribed antidepressant in Canada.
Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of …

Abstract Background Although the US Food and Drug Administration (FDA) recommended
upper limits for citalopram dosing in older adults due to risk of corrected-QT (QTc) …

Recently, Forest Laboratories warned about QTc prolongation associated with the use of
citalopram. After these reports, the FDA warned that citalopram should no longer be used at …

Objective A recent Food and Drug Administration (FDA) warning cautioned that citalopram
dosages exceeding 40 mg/day may cause abnormal heart rhythms, including torsade de …